Bottom line
Is CSMCX a good fund? The bottom line
CSMCX is the Institutional Class share class of Congress Small Cap Growth Fund, a managed small-cap mutual fund from Tortoise.
Its expense ratio is 1.01% — about $101 a year on every $10,000 invested, more expensive than 54% of small-cap funds we track.
It returned +8.3% over one year, +9.7% a year over five years, +13.6% a year over ten (as of Dec 31, 2025, per its prospectus).
With $2.0 billion in net assets and 41 holdings, its largest position is Ligand Pharmaceuticals Inc (3.9%) and the top 10 make up 32.7% of the portfolio.
What stands out
- 5-year return beat 79% of category peers
Updated Nov 19, 2026
What CSMCX invests in
The Congress Small Cap Growth Fund (the Small Cap Fund or Fund) seeks long-term capital growth.
The Small Cap Fund seeks to achieve its investment objective by investing at least 80% of its net assets (plus any borrowings for investment purposes) in the common stocks of small-capitalization companies. The Small Cap Fund defines small-capitalization companies as those companies with market capitalizations not exceeding the highest market capitalization in the Russell 2000 Growth Index during the preceding 12 months. As of the last reconstitution date, June 30, 2025, the market capitalization of companies in the Russell 2000 Growth Index ranged from $60.55 million to $15.72 billion. The Fund may invest any portion of the remaining 20% of its net assets in the equity securities of companies with market capitalizations that may be higher or lower than the range of issuer market capitalizations represented in the Russell 2000 Growth Index. The Small Cap Fund may invest in companies…
From the fund's prospectus (filed Feb 27, 2026).
CSMCX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| CSMCX | +8.3% | +9.7% | +13.6% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What CSMCX costs
On a $10,000 investment, CSMCX's 1.01% expense ratio costs about $101 a year. The prospectus estimates $1,236 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
CSMCX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Ligand Pharmaceuticals Inc LGND | 3.89% |
| 2 | Moog Inc MOG/A | 3.69% |
| 3 | TG Therapeutics Inc TGTX | 3.37% |
| 4 | Brinker International Inc EAT | 3.35% |
| 5 | Modine Manufacturing Co MOD | 3.30% |
| 6 | IMAX Corp IMAX | 3.10% |
| 7 | Enpro Inc NPO | 3.05% |
| 8 | InterDigital Inc IDCC | 3.03% |
| 9 | LivaNova PLC LIVN | 2.99% |
| 10 | Sensient Technologies Corp SXT | 2.89% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 32.7% of the fund. See all top 25 holdings and asset mix →